Resincal

Resincal

Manufacturer:

Laboratorios Rubio

Distributor:

Macropharma Corp
Concise Prescribing Info
Contents
Ca polystyrene sulfonate
Indications/Uses
Treatment of hyperkalemia resulting from acute & chronic renal failure.
Dosage/Direction for Use
Adult 15 g PO tid-qid. In case of vomiting & in patient w/ upper GI problems including paralytic ileus 30 g by rectal route suspended in 100 mL water, 2% methylcellulose or 5% glucose soln & left in the intestinal tract for 30 min-1 hr. Childn Acute hyperkalemia 1 g/kg daily in divided doses. Maintenance: 0.5 g/kg daily in divided doses. Neonate 0.5-1 g/kg by rectal route, diluted as in adults.
Administration
Should be taken on an empty stomach: Powd may be taken w/ a small amount of water (30-50 mL) or made into paste w/ sweetened liqd, jam or honey. Avoid fruit juices/carbonated drinks that contains high K.
Contraindications
History of hypersensitivity to polystyrene sulfonate resins. Obstructive bowel disease. Patients w/ serum K <5 mmol/L; conditions associated w/ hypercalcemia (eg, hyperparathyroidism, multiple myeloma, sarcoidosis or metastatic carcinoma). Oral administration & reduced gut motility (post-op or drug induced) in neonates.
Special Precautions
Monitor serum K, Na, Ca & Mg levels regularly. Pregnancy & lactation.
Adverse Reactions
Hypokalemia, hypercalcemia; symptoms of intestinal intolerance eg, nausea, vomiting, gastric irritation, anorexia, constipation & diarrhea, fecal impaction; GI concretions.
Drug Interactions
Digitalis, cation-donating agents, non-absorbable cation-donating antacids & laxatives eg, Mg or Al hydroxide, sorbitol.
MIMS Class
Electrolytes
ATC Classification
V03AE01 - polystyrene sulfonate ; Belongs to the class of drugs used in the treatment of hyperkalemia and hyperphosphatemia.
Presentation/Packing
Form
Resincal powd for oral susp 15 g
Packing/Price
26 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in